
### [NCIT:C35417](http://purl.obolibrary.org/obo/NCIT_C35417)
**Label:** Intrahepatic Cholangiocarcinoma

**Subclasses:** [NCIT:C134761](http://purl.obolibrary.org/obo/NCIT_C134761) (Stage III Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134760](http://purl.obolibrary.org/obo/NCIT_C134760) (Stage II Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134756](http://purl.obolibrary.org/obo/NCIT_C134756) (Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134514](http://purl.obolibrary.org/obo/NCIT_C134514) (Intrahepatic Cholangiocarcinoma by AJCC v7 Stage), [NCIT:C134755](http://purl.obolibrary.org/obo/NCIT_C134755) (Intrahepatic Cholangiocarcinoma by AJCC v8 Stage), [NCIT:C134764](http://purl.obolibrary.org/obo/NCIT_C134764) (Stage IV Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C41619](http://purl.obolibrary.org/obo/NCIT_C41619) (Signet Ring Cell Intrahepatic Cholangiocarcinoma), [NCIT:C41618](http://purl.obolibrary.org/obo/NCIT_C41618) (Mucin-Producing Intrahepatic Cholangiocarcinoma), [NCIT:C41617](http://purl.obolibrary.org/obo/NCIT_C41617) (Cholangiolocellular Carcinoma), [NCIT:C128807](http://purl.obolibrary.org/obo/NCIT_C128807) (Recurrent Intrahepatic Cholangiocarcinoma), [NCIT:C96949](http://purl.obolibrary.org/obo/NCIT_C96949) (Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma), [NCIT:C43848](http://purl.obolibrary.org/obo/NCIT_C43848) (Clear Cell Intrahepatic Cholangiocarcinoma), [NCIT:C88049](http://purl.obolibrary.org/obo/NCIT_C88049) (Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C88050](http://purl.obolibrary.org/obo/NCIT_C88050) (Stage I Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C88051](http://purl.obolibrary.org/obo/NCIT_C88051) (Stage II Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C134757](http://purl.obolibrary.org/obo/NCIT_C134757) (Stage I Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C88052](http://purl.obolibrary.org/obo/NCIT_C88052) (Stage III Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C96805](http://purl.obolibrary.org/obo/NCIT_C96805) (Peripheral Intrahepatic Cholangiocarcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0003704](http://purl.obolibrary.org/obo/UBERON_0003704) (intrahepatic bile duct) 62.50%
- [UBERON:0004823](http://purl.obolibrary.org/obo/UBERON_0004823) (intrahepatic bile duct epithelium) 54.17%
- [UBERON:0002330](http://purl.obolibrary.org/obo/UBERON_0002330) (exocrine system) 54.17%
- [UBERON:0001282](http://purl.obolibrary.org/obo/UBERON_0001282) (intralobular bile duct) 54.17%
- [UBERON:0001246](http://purl.obolibrary.org/obo/UBERON_0001246) (interlobular bile duct) 54.17%
- [UBERON:0003704](http://purl.obolibrary.org/obo/UBERON_0003704) (intrahepatic bile duct) and [UBERON:0035050](http://purl.obolibrary.org/obo/UBERON_0035050) (excretory duct) 54.17%
- [UBERON:0003704](http://purl.obolibrary.org/obo/UBERON_0003704) (intrahepatic bile duct) and [UBERON:0014716](http://purl.obolibrary.org/obo/UBERON_0014716) (interlobular duct) 54.17%
- Thing 52.82%
- [UBERON:0002394](http://purl.obolibrary.org/obo/UBERON_0002394) (bile duct) 39.89%
- [UBERON:0004820](http://purl.obolibrary.org/obo/UBERON_0004820) (bile duct epithelium) 33.03%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) 30.40%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 26.18%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 26.13%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 25.59%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 25.54%


